Shape changes in the erythrocyte membrane induced by the absorption enhancer didecanoylphosphatidylcholine

被引:5
作者
Vermehren, C
Hansen, HS
机构
[1] Royal Danish Sch Pharm, Dept Pharmaceut, DK-2100 Copenhagen, Denmark
[2] Royal Danish Sch Pharm, Dept Pharmacol, DK-2100 Copenhagen, Denmark
关键词
absorption enhancers; didecanoylphosphatidylcholine; erythrocytes; intranasal; shape changes;
D O I
10.1016/S0378-5173(98)00187-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The phospholipid didecanoylphosphatidylcholine (DDPC) has been shown to promote the nasal absorption of peptide drugs in rabbits. The absorption enhancing effect has been related to the cytotoxicity of DDPC; however, the mechanism of action is not completely elucidated. Thus, the aim of this study was to further understand the absorption promoting effect of DDPC by elucidation of the interaction of DDPC with plasma membranes (i.e. erythrocyte membranes). Incorporation of DDPC (0.01-0.27 mg/ml) into erythrocyte membranes was estimated and correlated with DDPC-induced shape changes of the cells as well as with DDPC-induced hemolysis. Incubation of erythrocytes for 30 min with DDPC resulted in discocyte-to-spherocyte shape changes with loss of concavity, as well as formation of a small number of echinocytes. Echinocyte formation might suggest that DDPC was incorporated into the outer leaflet of the erythrocyte membrane resulting in a crenated form. Spherocyte formation might result from incorporation of larger amounts of DDPC. The highest DDPC concentration induced cell aggregation. At this concentration, the amount of phospholipids in the erythrocyte membrane was increased by 5.3 mol% and the concentration-dependent hemolysis was almost complete. In contrast to the effect induced by DDPC, no shape changes of the erythrocyte were observed when incubated with long chain phosphatidylcholine (PC) from egg (0.05 mg/ml, 0.50 mg/ml). In this case only slight hemolysis was observed. Thus, these results supported previous assumptions that incorporation of medium chain phospholipids into cellular membranes happens very quickly, resulting in membrane disorders that might, in part, be responsible for the absorption enhancing effect and the cytotoxicity of the enhancer. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 36 条
[1]   EPITHELIAL TRANSPORT AND BIOAVAILABILITY OF INTRANASALLY ADMINISTERED HUMAN GROWTH-HORMONE FORMULATED WITH THE ABSORPTION ENHANCERS DIDECANOYL-L-ALPHA-PHOSPHATIDYLCHOLINE AND ALPHA-CYCLODEXTRIN IN RABBITS [J].
AGERHOLM, C ;
BASTHOLM, L ;
JOHANSEN, PB ;
NIELSEN, MH ;
ELLING, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (12) :1706-1711
[2]   INSULIN AND DIDECANOYL-L-ALPHA-PHOSPHATIDYLCHOLINE - INVITRO STUDY OF THE TRANSPORT THROUGH RABBIT NASAL MUCOSAL TISSUE [J].
BECHGAARD, E ;
JORGENSEN, L ;
LARSEN, R ;
GIZURARSON, S ;
CARSTENSEN, J ;
HVASS, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 89 (02) :147-153
[3]   EFFECTS OF EXOGENOUS PHOSPHOLIPIDS ON PLATELET ACTIVATION [J].
BRUNAUER, LS ;
HUESTIS, WH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1152 (01) :109-118
[4]   TRANSPORT OF INSULIN ACROSS RABBIT NASAL-MUCOSA INVITRO INDUCED BY DIDECANOYL-L-ALPHA-PHOSPHATIDYLCHOLINE [J].
CARSTENS, S ;
DANIELSEN, G ;
GULDHAMMER, B ;
FREDERIKSEN, O .
DIABETES, 1993, 42 (07) :1032-1040
[5]   NASAL ABSORPTION IN THE RAT .4. MEMBRANE-ACTIVITY OF ABSORPTION ENHANCERS [J].
CHANDLER, SG ;
THOMAS, NW ;
ILLUM, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 117 (02) :139-146
[6]  
CHIEN YW, 1987, CRC CR REV THER DRUG, V4, P67
[7]   ERYTHROCYTE MORPHOLOGY REFLECTS THE TRANSBILAYER DISTRIBUTION OF INCORPORATED PHOSPHOLIPIDS [J].
DALEKE, DL ;
HUESTIS, WH .
JOURNAL OF CELL BIOLOGY, 1989, 108 (04) :1375-1385
[8]   INCORPORATION AND TRANSLOCATION OF AMINOPHOSPHOLIPIDS IN HUMAN-ERYTHROCYTES [J].
DALEKE, DL ;
HUESTIS, WH .
BIOCHEMISTRY, 1985, 24 (20) :5406-5416
[9]   STATIC AND DYNAMIC LIPID ASYMMETRY IN CELL-MEMBRANES [J].
DEVAUX, PF .
BIOCHEMISTRY, 1991, 30 (05) :1163-1173
[10]   INTRANASAL ADMINISTRATION OF INSULIN WITH PHOSPHOLIPID AS ABSORPTION ENHANCER - PHARMACOKINETICS IN NORMAL SUBJECTS [J].
DREJER, K ;
VAAG, A ;
BECH, K ;
HANSEN, P ;
SORENSEN, AR ;
MYGIND, N .
DIABETIC MEDICINE, 1992, 9 (04) :335-340